Evidence map›Paper›PMID 40598719›Full record

ArticleInternal medicine journal2025

Design, implementation and evaluation of a model of care for patients with germline predisposition to haematological malignancy and bone marrow failure syndromes.

Lucy C Fox, Erin Goode, Nicole Den Elzen, Lin Cheng, Laura Barth, Kelsey Man, Anna Jarmolowicz, Mary Panjari, Stephanie Best, Karin Thursky and 4 more

Abstract read
In one paragraph

Article in Internal medicine journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Lucy C FoxClinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospitals, Melbourne, Victoria, Australia.ORCID 0000-0002-3855-8232
Erin GoodeMolecular Haematology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Nicole Den ElzenMolecular Haematology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.ORCID 0000-0003-0223-4954
Lin ChengSchool of Health Sciences, University of Melbourne, Melbourne, Victoria, Australia.
Laura BarthClinical Genetics, Monash Health, Melbourne, Victoria, Australia.
Kelsey ManMolecular Haematology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Anna JarmolowiczGenetic Health Western Australia, Perth, Western Australia, Australia.
Mary PanjariMolecular Haematology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Stephanie BestSchool of Health Sciences, University of Melbourne, Melbourne, Victoria, Australia.ORCID 0000-0002-1107-8976
Karin ThurskySir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.ORCID 0000-0002-7400-232X
Paul JamesSir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.ORCID 0000-0002-4361-4657
Ashish BajelClinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospitals, Melbourne, Victoria, Australia.ORCID 0000-0002-3755-7334
David RitchieClinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospitals, Melbourne, Victoria, Australia.ORCID 0000-0001-7329-6605
Piers BlomberyClinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospitals, Melbourne, Victoria, Australia.ORCID 0000-0002-9902-0022

Funding

Maddie Riewoldt's Vision MRV0016
6 · The paper itself

Abstract

backgroundThe bone marrow failure syndromes (BMFS) are clinically heterogeneous conditions with both inherited and acquired etiologies. Optimal care is often challenged by the complexity of these disorders and gaps in healthcare delivery. The Evaluating Multidisciplinary Bone maRrow fAilure CarE (EMBRACE) study is a multi-stage hybrid implementation-effectiveness study designed to explore the nature of issues faced by patients with BMFS and their physicians, and to develop, implement, and evaluate a comprehensive model of care.

methodsTo identify barriers to optimal BMFS care, we conducted semi-structured interviews with patients and patient advocates, followed by a nationwide survey of physicians involved in BMFS management. Thematic analysis was performed on interview data, and survey responses were analysed to identify common challenges and areas for improvement.

resultsInterview themes elicited included: (i) limited disease-specific awareness and resources, (ii) challenges in attaining genetic care, (iii) the ongoing impact of complex care needs, (iv) the perceived value of genetic testing, and (v) the importance of specialised healthcare professionals. Physician surveys indicated a desire for affordable genomic testing, assistance with result interpretation and genetic counselling/cascade testing of extended kindred, a forum for complex case discussion and advice regarding management strategies. Responses from patients, advocates and physicians, along with existing best-practice guidelines, were then used to develop a 10-component model of care aimed at addressing identified issues.

conclusionsThe EMBRACE study has established a stakeholder-informed, multidisciplinary care framework for patients with BMFS. This care programme continues to undergo evaluation and audit consistent with principles of an implementation-effectiveness study to determine both patient and physician satisfaction, and iterative refinement to provide optimum care.

Indexed as

Bone Marrow DiseasesBone Marrow Failure DisordersGenetic Predisposition to DiseaseHematologic NeoplasmsHemoglobinuria, ParoxysmalAdultFemaleGenetic TestingGerm-Line MutationHumansMaleMiddle AgedSurveys and Questionnairesbone marrow failure syndromegenetic counsellinghereditary predisposition to haematological malignancy

Identifiers

PMID40598719
PMCPMC12347311

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.